Christine Simmon, Executive Director of AAM’s Biosimilars Council, reacts to the recent release of FDA’s Biosimilars Action Plan
Christine Simmon, Executive Director of AAM’s Biosimilars Council, reacts to the recent release of FDA’s Biosimilars Action Plan
Generic and biosimilar medicines make it easier and more affordable for patients to live healthier lives.
